{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T22:12:10Z","timestamp":1789164730514,"version":"build-2803163510"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"EuCARE Project funded by the European Union's Horizon Europe Research and Innovation Programme","award":["Grant Agreement No 101046016"],"award-info":[{"award-number":["Grant Agreement No 101046016"]}]},{"name":"EuCARE Project funded by the European Union's Horizon Europe Research and Innovation Programme","award":["Grant Agreement No 101046016"],"award-info":[{"award-number":["Grant Agreement No 101046016"]}]},{"name":"EuCARE Project funded by the European Union's Horizon Europe Research and Innovation Programme","award":["Grant Agreement No 101046016"],"award-info":[{"award-number":["Grant Agreement No 101046016"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13305-7","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T17:46:07Z","timestamp":1776102367000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cell-free nucleic acids as a non-invasive biomarker for predicting COVID-19 disease severity and outcome: a retrospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Ieva","family":"Kubiliute","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurgita","family":"Urboniene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausta","family":"Majauskaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielius","family":"Tamasauskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dovile","family":"Juozapaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ligita","family":"Jancoriene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"key":"13305_CR1","unstructured":"COVID-19 deaths | WHO COVID-19 dashboard. https:\/\/data.who.int\/dashboards\/covid19\/deaths?n=c. Accessed 27 Jan 2026."},{"issue":"2","key":"13305_CR2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s15010-020-01531-3","volume":"49","author":"B Salzberger","year":"2021","unstructured":"Salzberger B, Buder F, Lampl B, Ehrenstein B, Hitzenbichler F, Holzmann T, et al. Epidemiology of SARS-CoV-2. Infection. 2021;49(2):233\u20139.","journal-title":"Infection"},{"issue":"10229","key":"13305_CR3","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054\u201362.","journal-title":"Lancet"},{"issue":"3","key":"13305_CR4","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3390\/v13030419","volume":"13","author":"F Qeadan","year":"2021","unstructured":"Qeadan F, Tingey B, Gu LY, Packard AH, Erdei E, Saeed AI. Prognostic Values of Serum Ferritin and D-Dimer Trajectory in Patients with COVID-19. Viruses. 2021;13(3):419.","journal-title":"Viruses"},{"issue":"2","key":"13305_CR5","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1002\/jmv.26411","volume":"93","author":"J Khinda","year":"2021","unstructured":"Khinda J, Janjua NZ, Cheng S, van den Heuvel ER, Bhatti P, Darvishian M. Association between markers of immune response at hospital admission and COVID-19 disease severity and mortality: A meta-analysis and meta-regression. J Med Virol. 2021;93(2):1078\u201398.","journal-title":"J Med Virol"},{"issue":"5","key":"13305_CR6","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.kint.2020.03.005","volume":"97","author":"Y Cheng","year":"2020","unstructured":"Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97(5):829\u201338.","journal-title":"Kidney Int"},{"issue":"1","key":"13305_CR7","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.medj.2020.09.001","volume":"2","author":"YM Liu","year":"2021","unstructured":"Liu YM, Xie J, Chen MM, Zhang X, Cheng X, Li H, et al. Kidney Function Indicators Predict Adverse Outcomes of COVID-19. Med. 2021;2(1):38\u201348.","journal-title":"Med"},{"key":"13305_CR8","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.ijid.2021.02.113","volume":"105","author":"A Wibowo","year":"2021","unstructured":"Wibowo A, Pranata R, Akbar MR, Purnomowati A, Martha JW. Prognostic performance of troponin in COVID-19: A diagnostic meta-analysis and meta-regression. Int J Infect Dis. 2021;105:312\u20138.","journal-title":"Int J Infect Dis"},{"issue":"6","key":"13305_CR9","doi-asserted-by":"publisher","first-page":"842","DOI":"10.3390\/medicina60060842","volume":"60","author":"I Kubiliute","year":"2024","unstructured":"Kubiliute I, Urboniene J, Majauskaite F, Bobkov E, Svetikas L, Jancoriene L. Elevated Cardiac Troponin I as a Mortality Predictor in Hospitalised COVID-19 Patients. Medicina. 2024;60(6):842.","journal-title":"Medicina"},{"issue":"8","key":"13305_CR10","doi-asserted-by":"publisher","first-page":"e0290656","DOI":"10.1371\/journal.pone.0290656","volume":"18","author":"I Kubiliute","year":"2023","unstructured":"Kubiliute I, Vitkauskaite M, Urboniene J, Svetikas L, Zablockiene B, Jancoriene L. Clinical characteristics and predictors for in-hospital mortality in adult COVID-19 patients: A retrospective single center cohort study in Vilnius, Lithuania. PLoS ONE. 2023;18(8):e0290656.","journal-title":"PLoS ONE"},{"issue":"1","key":"13305_CR11","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s12985-024-02523-7","volume":"21","author":"Q Xin","year":"2024","unstructured":"Xin Q, Liang X, Yang J, Wang X, Hu F, Jiang M, et al. Metabolomic alterations in the plasma of patients with various clinical manifestations of COVID-19. Virol J. 2024;21(1):266.","journal-title":"Virol J"},{"issue":"1","key":"13305_CR12","doi-asserted-by":"publisher","first-page":"4963","DOI":"10.1038\/s41598-025-87288-x","volume":"15","author":"R Mallol","year":"2025","unstructured":"Mallol R, Rombauts A, Abelenda-Alonso G, Gudiol C, Balsalobre M, Carratal\u00e0 J. Metabolomic profile of severe COVID-19 and a signature predictive of progression towards severe disease status: a prospective cohort study (METCOVID). Sci Rep. 2025;15(1):4963.","journal-title":"Sci Rep"},{"issue":"1","key":"13305_CR13","doi-asserted-by":"publisher","first-page":"e23320","DOI":"10.1016\/j.heliyon.2023.e23320","volume":"10","author":"NC Harriott","year":"2023","unstructured":"Harriott NC, Ryan AL. Proteomic profiling identifies biomarkers of COVID-19 severity. Heliyon. 2023;10(1):e23320.","journal-title":"Heliyon"},{"issue":"1","key":"13305_CR14","doi-asserted-by":"publisher","first-page":"20315","DOI":"10.1038\/s41598-023-46343-1","volume":"13","author":"S Castro-Pearson","year":"2023","unstructured":"Castro-Pearson S, Samorodnitsky S, Yang K, Lotfi-Emran S, Ingraham NE, Bramante C, et al. Development of a proteomic signature associated with severe disease for patients with COVID-19 using data from 5 multicenter, randomized, controlled, and prospective studies. Sci Rep. 2023;13(1):20315.","journal-title":"Sci Rep"},{"issue":"3","key":"13305_CR15","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3390\/biom15030393","volume":"15","author":"I Alloza-Moral","year":"2025","unstructured":"Alloza-Moral I, Aldekoa-Etxabe A, Tulloch-Navarro R, Fiat-Arriola A, Mar C, Urrechaga E, et al. Genetic Analysis and Predictive Modeling of COVID-19 Severity in a Hospital-Based Patient Cohort. Biomolecules. 2025;15(3):393.","journal-title":"Biomolecules"},{"issue":"1","key":"13305_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-02905-8","volume":"7","author":"A Zinkova","year":"2017","unstructured":"Zinkova A, Brynychova I, Svacina A, Jirkovska M, Korabecna M. Cell-free DNA from human plasma and serum differs in content of telomeric sequences and its ability to promote immune response. Sci Rep. 2017;7(1):1\u20138.","journal-title":"Sci Rep"},{"issue":"10","key":"13305_CR17","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1111\/jcmm.12625","volume":"19","author":"M Fernandez-Mercado","year":"2015","unstructured":"Fernandez-Mercado M, Manterola L, Larrea E, Goicoechea I, Arestin M, Armesto M, et al. The circulating transcriptome as a source of non-invasive cancer biomarkers: concepts and controversies of non-coding and coding RNA in body fluids. J Cell Mol Med. 2015;19(10):2307\u201323.","journal-title":"J Cell Mol Med"},{"key":"13305_CR18","doi-asserted-by":"publisher","first-page":"101987","DOI":"10.1016\/j.molmet.2024.101987","volume":"87","author":"M Mareboina","year":"2024","unstructured":"Mareboina M, Deng E, Mouratidis I, Yee NS, Pitteloud N, Georgakopoulos-Soares I, et al. A review on cell-free RNA profiling: Insights into metabolic diseases and predictive value for bariatric surgery outcomes. Mol Metab. 2024;87:101987.","journal-title":"Mol Metab"},{"issue":"3","key":"13305_CR19","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1111\/brv.12413","volume":"93","author":"J Aucamp","year":"2018","unstructured":"Aucamp J, Bronkhorst AJ, Badenhorst CPS, Pretorius PJ. The diverse origins of circulating cell-free DNA in the human body: a critical re-evaluation of the literature. Biol Rev. 2018;93(3):1649\u201383.","journal-title":"Biol Rev"},{"issue":"17","key":"13305_CR20","doi-asserted-by":"publisher","first-page":"9110","DOI":"10.3390\/ijms22179110","volume":"22","author":"FS de Miranda","year":"2021","unstructured":"de Miranda FS, Barauna VG, Dos Santos L, Costa G, Vassallo PF, Campos LCG. Properties and Application of Cell-Free DNA as a Clinical Biomarker. Int J Mol Sci. 2021;22(17):9110.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"13305_CR21","doi-asserted-by":"publisher","first-page":"1286095","DOI":"10.1080\/20013078.2017.1286095","volume":"6","author":"B Mateescu","year":"2017","unstructured":"Mateescu B, Kowal EJK, van Balkom BWM, Bartel S, Bhattacharyya SN, Buz\u00e1s EI, et al. Obstacles and opportunities in the functional analysis of extracellular vesicle RNA - an ISEV position paper. J Extracell Vesicles. 2017;6(1):1286095.","journal-title":"J Extracell Vesicles"},{"issue":"12","key":"13305_CR22","doi-asserted-by":"publisher","first-page":"5501","DOI":"10.7150\/thno.45554","volume":"10","author":"D Han","year":"2020","unstructured":"Han D, Li R, Shi J, Tan P, Zhang R, Li J. Liquid biopsy for infectious diseases: a focus on microbial cell-free DNA sequencing. Theranostics. 2020;10(12):5501.","journal-title":"Theranostics"},{"key":"13305_CR23","doi-asserted-by":"publisher","first-page":"639233","DOI":"10.3389\/fcell.2021.639233","volume":"9","author":"YY Yan","year":"2021","unstructured":"Yan YY, Guo QR, Wang FH, Adhikari R, Zhu ZY, Zhang HY, et al. Cell-Free DNA: Hope and Potential Application in Cancer. Front Cell Dev Biol. 2021;9:639233.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"13305_CR24","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1038\/s41467-021-22444-1","volume":"12","author":"MH Larson","year":"2021","unstructured":"Larson MH, Pan W, Kim HJ, Mauntz RE, Stuart SM, Pimentel M, et al. A comprehensive characterization of the cell-free transcriptome reveals tissue- and subtype-specific biomarkers for cancer detection. Nat Commun. 2021;12(1):2357.","journal-title":"Nat Commun"},{"issue":"6","key":"13305_CR25","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1172\/JCI109992","volume":"66","author":"L Raptis","year":"1980","unstructured":"Raptis L, Menard HA. Quantitation and characterization of plasma DNA in normals and patients with systemic lupus erythematosus. J Clin Invest. 1980;66(6):1391\u20139.","journal-title":"J Clin Invest"},{"issue":"6","key":"13305_CR26","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/1756-185X.12959","volume":"20","author":"T Hashimoto","year":"2017","unstructured":"Hashimoto T, Yoshida K, Hashimoto N, Nakai A, Kaneshiro K, Suzuki K, et al. Circulating cell free DNA: a marker to predict the therapeutic response for biological DMARDs in rheumatoid arthritis. Int J Rheum Dis. 2017;20(6):722\u201330.","journal-title":"Int J Rheum Dis"},{"issue":"4","key":"13305_CR27","doi-asserted-by":"publisher","first-page":"e2113476118","DOI":"10.1073\/pnas.2113476118","volume":"119","author":"AP Cheng","year":"2022","unstructured":"Cheng AP, Cheng MP, Loy CJ, Lenz JS, Chen K, Smalling S, et al. Cell-free DNA profiling informs all major complications of hematopoietic cell transplantation. Proc Natl Acad Sci U S A. 2022;119(4):e2113476118.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"241","key":"13305_CR28","doi-asserted-by":"publisher","first-page":"241ra77","DOI":"10.1126\/scitranslmed.3007803","volume":"6","author":"I De Vlaminck","year":"2014","unstructured":"De Vlaminck I, Valantine HA, Snyder TM, Strehl C, Cohen G, Luikart H, et al. Circulating cell-free DNA enables noninvasive diagnosis of heart transplant rejection. Sci Transl Med. 2014;6(241):241ra77.","journal-title":"Sci Transl Med"},{"issue":"1","key":"13305_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-50044-z","volume":"9","author":"JA Stortz","year":"2019","unstructured":"Stortz JA, Hawkins RB, Holden DC, Raymond SL, Wang Z, Brakenridge SC, et al. Cell-free nuclear, but not mitochondrial, DNA concentrations correlate with the early host inflammatory response after severe trauma. Sci Rep. 2019;9(1):1\u201310.","journal-title":"Sci Rep"},{"issue":"1","key":"13305_CR30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s40635-019-0251-4","volume":"7","author":"NL Jackson Chornenki","year":"2019","unstructured":"Jackson Chornenki NL, Coke R, Kwong AC, Dwivedi DJ, Xu MK, McDonald E, et al. Comparison of the source and prognostic utility of cfDNA in trauma and sepsis. Intensive Care Med Exp. 2019;7(1):29.","journal-title":"Intensive Care Med Exp"},{"issue":"10","key":"13305_CR31","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.3390\/biomedicines12102190","volume":"12","author":"D Zhang","year":"2024","unstructured":"Zhang D, Guo J, Shi C, Wang Y, Zhang Y, Zhang X, et al. MPO-DNA Complexes and cf-DNA in Patients with Sepsis and Their Clinical Value. Biomedicines. 2024;12(10):2190.","journal-title":"Biomedicines"},{"key":"13305_CR32","doi-asserted-by":"crossref","unstructured":"Arshad O, Gadawska I, Sattha B, C\u00f4t\u00e9 HCF, Hsieh AYY. Elevated cell-free mitochondrial DNA in filtered plasma is associated with HIV infection and inflammation. J Acquir Immune Defic Syndr (1988). 2018;78(1):111\u20138.","DOI":"10.1097\/QAI.0000000000001650"},{"issue":"2","key":"13305_CR33","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s12291-022-01082-4","volume":"38","author":"S Mishra","year":"2023","unstructured":"Mishra S, Dubey DB, Agarwal K, Dubey DB, Verma S, Shabbir N, et al. Circulating Cell-Free DNA Level in Prediction of COVID-19 Severity and Mortality: Correlation of with Haematology and Serum Biochemical Parameters. Indian J Clin Biochem. 2023;38(2):172\u201381.","journal-title":"Indian J Clin Biochem"},{"issue":"1","key":"13305_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-024-68433-4","volume":"14","author":"A Tanaka","year":"2024","unstructured":"Tanaka A, Wakayama K, Fukuda Y, Ohta S, Homma T, Ando K, et al. Increased levels of circulating cell-free DNA in COVID-19 patients with respiratory failure. Sci Rep. 2024;14(1):1\u201311.","journal-title":"Sci Rep"},{"key":"13305_CR35","doi-asserted-by":"crossref","unstructured":"Andargie TE, Tsuji N, Seifuddin F, Jang MK, Yuen PST, Kong H, et al. Cell-free DNA maps COVID-19 tissue injury and risk of death and can cause tissue injury. JCI Insight. 2021;6(7).","DOI":"10.1172\/jci.insight.147610"},{"issue":"11","key":"13305_CR36","doi-asserted-by":"publisher","first-page":"e138999","DOI":"10.1172\/jci.insight.138999","volume":"5","author":"Y Zuo","year":"2020","unstructured":"Zuo Y, Yalavarthi S, Shi H, Gockman K, Zuo M, Madison JA, et al. Neutrophil extracellular traps in COVID-19. JCI Insight. 2020;5(11):e138999.","journal-title":"JCI Insight"},{"key":"13305_CR37","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.ebiom.2019.10.008","volume":"49","author":"AT Madsen","year":"2019","unstructured":"Madsen AT, Hojbjerg JA, Sorensen BS, Winther-Larsen A. Day-to-day and within-day biological variation of cell-free DNA. EBioMedicine. 2019;49:284\u201390.","journal-title":"EBioMedicine"},{"key":"13305_CR38","doi-asserted-by":"publisher","first-page":"e16072","DOI":"10.7717\/peerj.16072","volume":"11","author":"K Hoeter","year":"2023","unstructured":"Hoeter K, Neuberger E, Fischer S, Herbst M, Ju\u0161kevi\u010di\u016bt\u0117 E, Enders K, et al. Evidence for the utility of cfDNA plasma concentrations to predict disease severity in COVID-19: a retrospective pilot study. PeerJ. 2023;11:e16072.","journal-title":"PeerJ"},{"issue":"10","key":"13305_CR39","doi-asserted-by":"publisher","first-page":"e202503417","DOI":"10.26508\/lsa.202503417","volume":"8","author":"R Ben-Ami","year":"2025","unstructured":"Ben-Ami R, Loyfer N, Cohen E, Fialkoff G, Sharkia I, Piyanzin S, et al. Epigenetic liquid biopsies reveal endothelial turnover and erythropoiesis in asymptomatic COVID-19. Life Sci Alliance. 2025;8(10):e202503417.","journal-title":"Life Sci Alliance"},{"issue":"3","key":"13305_CR40","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1177\/1753425921995577","volume":"27","author":"R Hammad","year":"2021","unstructured":"Hammad R, Eldosoky MAER, Fouad SH, Elgendy A, Tawfeik AM, Alboraie M, et al. Circulating cell-free DNA, peripheral lymphocyte subsets alterations and neutrophil lymphocyte ratio in assessment of COVID-19 severity. Innate Immun. 2021;27(3):240.","journal-title":"Innate Immun"},{"issue":"1","key":"13305_CR41","first-page":"9339411","volume":"2022","author":"BM Henry","year":"2022","unstructured":"Henry BM, De Oliveira MHS, Cheruiyot I, Benoit J, Rose J, Favaloro EJ, et al. Cell-Free DNA, Neutrophil extracellular traps (NETs), and Endothelial Injury in Coronavirus Disease 2019\u2013 (COVID-19\u2013) Associated Acute Kidney Injury. Mediators Inflamm. 2022;2022(1):9339411.","journal-title":"Mediators Inflamm"},{"issue":"4","key":"13305_CR42","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00281-013-0384-6","volume":"35","author":"N Branzk","year":"2013","unstructured":"Branzk N, Papayannopoulos V. Molecular mechanisms regulating NETosis in infection and disease. Semin Immunopathol. 2013;35(4):513\u201330.","journal-title":"Semin Immunopathol"},{"issue":"2","key":"13305_CR43","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1093\/infdis\/jiae252","volume":"230","author":"A Meier","year":"2024","unstructured":"Meier A, Sakoulas G, Nizet V, Ulloa ER. Neutrophil Extracellular Traps: An Emerging Therapeutic Target to Improve Infectious Disease Outcomes. J Infect Dis. 2024;230(2):514\u201321.","journal-title":"J Infect Dis"},{"key":"13305_CR44","doi-asserted-by":"publisher","first-page":"100280","DOI":"10.1016\/j.jtauto.2025.100280","volume":"10","author":"DM Monsalve","year":"2025","unstructured":"Monsalve DM, Acosta-Ampudia Y, Acosta NG, Celis-Andrade M, \u015eahin A, Yilmaz AM, et al. NETosis: A key player in autoimmunity, COVID-19, and long COVID. J Transl Autoimmun. 2025;10:100280.","journal-title":"J Transl Autoimmun"},{"key":"13305_CR45","doi-asserted-by":"publisher","first-page":"838011","DOI":"10.3389\/fimmu.2022.838011","volume":"13","author":"Y Zhu","year":"2022","unstructured":"Zhu Y, Chen X, Liu X. NETosis and Neutrophil Extracellular Traps in COVID-19: Immunothrombosis and Beyond. Front Immunol. 2022;13:838011.","journal-title":"Front Immunol"},{"issue":"12","key":"13305_CR46","doi-asserted-by":"publisher","first-page":"e20201129","DOI":"10.1084\/jem.20201129","volume":"217","author":"FP Veras","year":"2020","unstructured":"Veras FP, Pontelli MC, Silva CM, Toller-Kawahisa JE, de Lima M, Nascimento DC, et al. SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology. J Exp Med. 2020;217(12):e20201129.","journal-title":"J Exp Med"},{"issue":"6","key":"13305_CR47","doi-asserted-by":"publisher","first-page":"e20200652","DOI":"10.1084\/jem.20200652","volume":"217","author":"BJ Barnes","year":"2020","unstructured":"Barnes BJ, Adrover JM, Baxter-Stoltzfus A, Borczuk A, Cools-Lartigue J, Crawford JM, et al. Targeting potential drivers of COVID-19: Neutrophil extracellular traps. J Exp Med. 2020;217(6):e20200652.","journal-title":"J Exp Med"},{"issue":"10","key":"13305_CR48","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1182\/blood.2020007008","volume":"136","author":"EA Middleton","year":"2020","unstructured":"Middleton EA, He XY, Denorme F, Campbell RA, Ng D, Salvatore SP, et al. Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood. 2020;136(10):1169\u201379.","journal-title":"Blood"},{"issue":"11","key":"13305_CR49","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1097\/TP.0000000000003240","volume":"104","author":"S Dholakia","year":"2020","unstructured":"Dholakia S, De Vlaminck I, Khush KK. Adding Insult on Injury: Immunogenic Role for Donor-derived Cell-free DNA? Transplantation. 2020;104(11):2266\u201371.","journal-title":"Transplantation"},{"issue":"4","key":"13305_CR50","doi-asserted-by":"publisher","first-page":"143299","DOI":"10.1172\/jci.insight.143299","volume":"6","author":"D Scozzi","year":"2021","unstructured":"Scozzi D, Cano M, Ma L, Zhou D, Zhu JH, O\u2019Halloran JA, et al. Circulating mitochondrial DNA is an early indicator of severe illness and mortality from COVID-19. JCI Insight. 2021;6(4):143299.","journal-title":"JCI Insight"},{"issue":"6","key":"13305_CR51","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1093\/infdis\/jir863","volume":"205","author":"SL Stramer","year":"2012","unstructured":"Stramer SL, Collins C, Nugent T, Wang X, Fuschino M, Heitman JW, et al. Sensitive Detection Assays for Influenza RNA Do Not Reveal Viremia in US Blood Donors. J Infect Dis. 2012;205(6):886\u201394.","journal-title":"J Infect Dis"},{"issue":"8","key":"13305_CR52","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1093\/cid\/ciaa449","volume":"71","author":"X Chen","year":"2020","unstructured":"Chen X, Zhao B, Qu Y, Chen Y, Xiong J, Feng Y, et al. Detectable Serum Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load (RNAemia) Is Closely Correlated With Drastically Elevated Interleukin 6 Level in Critically Ill Patients With Coronavirus Disease 2019. Clin Infect Dis. 2020;71(8):1937\u201342.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"13305_CR53","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.3390\/v15071560","volume":"15","author":"MJ Lawrence Panchali","year":"2023","unstructured":"Lawrence Panchali MJ, Kim CM, Seo JW, Kim DY, Yun NR, Kim DM. SARS-CoV-2 RNAemia and Disease Severity in COVID-19 Patients. Viruses. 2023;15(7):1560.","journal-title":"Viruses"},{"issue":"1","key":"13305_CR54","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1080\/22221751.2020.1732837","volume":"9","author":"W Chen","year":"2020","unstructured":"Chen W, Lan Y, Yuan X, Deng X, Li Y, Cai X, et al. Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity. Emerg Microbes Infect. 2020;9(1):469\u201373.","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"13305_CR55","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1186\/s13054-020-03398-0","volume":"24","author":"JF Bermejo-Martin","year":"2020","unstructured":"Bermejo-Martin JF, Gonz\u00e1lez-Rivera M, Almansa R, Micheloud D, Tedim AP, Dom\u00ednguez-Gil M, et al. Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19. Crit Care. 2020;24(1):691.","journal-title":"Crit Care"},{"key":"13305_CR56","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-Serrano DA, Roy-Vallejo E, Zurita Cruz ND, Mart\u00edn Ram\u00edrez A, Rodr\u00edguez-Garc\u00eda SC, Arevalillo-Fern\u00e1ndez N, et al. Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients. Sci Rep. 2021;11(1):13134.","DOI":"10.1101\/2021.01.14.21249372"},{"key":"13305_CR57","doi-asserted-by":"publisher","first-page":"181","DOI":"10.12688\/wellcomeopenres.16002.2","volume":"5","author":"PC Matthews","year":"2020","unstructured":"Matthews PC, Andersson MI, Arancibia-Carcamo CV, Auckland K, Baillie JK, Barnes E, et al. SARS-CoV-2 RNA detected in blood products from patients with COVID-19 is not associated with infectious virus. Wellcome Open Res. 2020;5:181.","journal-title":"Wellcome Open Res"},{"key":"13305_CR58","doi-asserted-by":"publisher","first-page":"1385041","DOI":"10.3389\/fcell.2024.1385041","volume":"12","author":"H Peng","year":"2024","unstructured":"Peng H, Pan M, Zhou Z, Chen C, Xing X, Cheng S, et al. The impact of preanalytical variables on the analysis of cell-free DNA from blood and urine samples. Front Cell Dev Biol. 2024;12:1385041.","journal-title":"Front Cell Dev Biol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13305-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13305-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13305-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T04:16:18Z","timestamp":1779682578000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13305-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13305"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13305-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]},"assertion":[{"value":"27 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki. This study was approved on June 6, 2023, by the Vilnius Regional Biomedical Research Ethics Committee (approval number 2023\/6-1521-982, with amendments approved on November 21, 2024, and March 7, 2025), which waived the requirement for obtaining the study-specific written informed consent form. All participants had signed the informed, written consent form for biobanking in Vilnius Santaros Klinikos Biobank.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1010"}}